The effect of phencyclidine on dopamine metabolism in the mouse brain

Kenneth M. Johnson; Kevin C. Oeffinger

doi:10.1016/0024-3205(81)90080-1

The effect of phencyclidine on dopamine metabolism in the mouse brain

Kenneth M. Johnson, Kevin C. Oeffinger

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

The administration of phencyclidine (PCP) to mice resulted in no change in brain levels of tyrosine, dopamine (DA), norepinephrine (NE), or homovanillic acid (HVA). Although PCP reduced plasma tyrosine levels, no effect of PCP on the utilization of DA of NE after blockade of synthesis with α-methyl-p-tyrosine (AMPT) was observed. In addition, PCP did not affect the probenecid-induced accumulation of HVA. However, PCP was observed to potentiate the haloperidol-induced increase in HVA concentration, and the haloperidol-induced decline in DA levels after AMPT. The former effect was blocked by baclofen, suggesting that PCP mobilizes DA for impulse-dependent release. This effect could not be attributed to an antagonism of presynaptic DA receptors. These effects are similar to those of the "non-amphetamine" stimulant class of drugs.

Original language	English (US)
Pages (from-to)	361-369
Number of pages	9
Journal	Life Sciences
Volume	28
Issue number	4
DOIs	https://doi.org/10.1016/0024-3205(81)90080-1
State	Published - Jan 26 1981
Externally published	Yes

ASJC Scopus subject areas

General Pharmacology, Toxicology and Pharmaceutics
General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1016/0024-3205(81)90080-1

Cite this

@article{0e6a903591a84ca89a6d2bea8e9b00b5,

title = "The effect of phencyclidine on dopamine metabolism in the mouse brain",

abstract = "The administration of phencyclidine (PCP) to mice resulted in no change in brain levels of tyrosine, dopamine (DA), norepinephrine (NE), or homovanillic acid (HVA). Although PCP reduced plasma tyrosine levels, no effect of PCP on the utilization of DA of NE after blockade of synthesis with α-methyl-p-tyrosine (AMPT) was observed. In addition, PCP did not affect the probenecid-induced accumulation of HVA. However, PCP was observed to potentiate the haloperidol-induced increase in HVA concentration, and the haloperidol-induced decline in DA levels after AMPT. The former effect was blocked by baclofen, suggesting that PCP mobilizes DA for impulse-dependent release. This effect could not be attributed to an antagonism of presynaptic DA receptors. These effects are similar to those of the {"}non-amphetamine{"} stimulant class of drugs.",

author = "Johnson, {Kenneth M.} and Oeffinger, {Kevin C.}",

note = "Funding Information: This work was supported by a grant from the USPHS (DA-02073).",

year = "1981",

month = jan,

day = "26",

doi = "10.1016/0024-3205(81)90080-1",

language = "English (US)",

volume = "28",

pages = "361--369",

journal = "Life Sciences",

issn = "0024-3205",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - The effect of phencyclidine on dopamine metabolism in the mouse brain

AU - Johnson, Kenneth M.

AU - Oeffinger, Kevin C.

N1 - Funding Information: This work was supported by a grant from the USPHS (DA-02073).

PY - 1981/1/26

Y1 - 1981/1/26

N2 - The administration of phencyclidine (PCP) to mice resulted in no change in brain levels of tyrosine, dopamine (DA), norepinephrine (NE), or homovanillic acid (HVA). Although PCP reduced plasma tyrosine levels, no effect of PCP on the utilization of DA of NE after blockade of synthesis with α-methyl-p-tyrosine (AMPT) was observed. In addition, PCP did not affect the probenecid-induced accumulation of HVA. However, PCP was observed to potentiate the haloperidol-induced increase in HVA concentration, and the haloperidol-induced decline in DA levels after AMPT. The former effect was blocked by baclofen, suggesting that PCP mobilizes DA for impulse-dependent release. This effect could not be attributed to an antagonism of presynaptic DA receptors. These effects are similar to those of the "non-amphetamine" stimulant class of drugs.

AB - The administration of phencyclidine (PCP) to mice resulted in no change in brain levels of tyrosine, dopamine (DA), norepinephrine (NE), or homovanillic acid (HVA). Although PCP reduced plasma tyrosine levels, no effect of PCP on the utilization of DA of NE after blockade of synthesis with α-methyl-p-tyrosine (AMPT) was observed. In addition, PCP did not affect the probenecid-induced accumulation of HVA. However, PCP was observed to potentiate the haloperidol-induced increase in HVA concentration, and the haloperidol-induced decline in DA levels after AMPT. The former effect was blocked by baclofen, suggesting that PCP mobilizes DA for impulse-dependent release. This effect could not be attributed to an antagonism of presynaptic DA receptors. These effects are similar to those of the "non-amphetamine" stimulant class of drugs.

UR - http://www.scopus.com/inward/record.url?scp=0019365748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019365748&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(81)90080-1

DO - 10.1016/0024-3205(81)90080-1

M3 - Article

C2 - 7194409

AN - SCOPUS:0019365748

SN - 0024-3205

VL - 28

SP - 361

EP - 369

JO - Life Sciences

JF - Life Sciences

IS - 4

ER -

The effect of phencyclidine on dopamine metabolism in the mouse brain

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this